4//SEC Filing
MVA Investors, LLC 4
Accession 0000899243-20-020687
CIK 0001808865other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:38 PM ET
Size
21.1 KB
Accession
0000899243-20-020687
Insider Transaction Report
Form 4
Boxer Asset Management Inc.
10% Owner
Transactions
- Conversion
Series B-2 Preferred Stock
2020-07-28−158,687→ 0 total→ Common Stock (48,691 underlying) - Conversion
Common Stock
2020-07-28+2,943,568→ 2,943,568 total - Purchase
Common Stock
2020-07-28$19.00/sh+23,552$447,488→ 72,243 total - Conversion
Common Stock
2020-07-28+48,691→ 48,691 total - Purchase
Common Stock
2020-07-28$19.00/sh+1,401,448$26,627,512→ 4,345,016 total - Conversion
Series B-2 Preferred Stock
2020-07-28−9,593,086→ 0 total→ Common Stock (2,943,568 underlying)
LEWIS JOSEPH
10% Owner
Transactions
- Purchase
Common Stock
2020-07-28$19.00/sh+1,401,448$26,627,512→ 4,345,016 total - Purchase
Common Stock
2020-07-28$19.00/sh+23,552$447,488→ 72,243 total - Conversion
Common Stock
2020-07-28+2,943,568→ 2,943,568 total - Conversion
Common Stock
2020-07-28+48,691→ 48,691 total - Conversion
Series B-2 Preferred Stock
2020-07-28−9,593,086→ 0 total→ Common Stock (2,943,568 underlying) - Conversion
Series B-2 Preferred Stock
2020-07-28−158,687→ 0 total→ Common Stock (48,691 underlying)
MVA Investors, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-07-28+2,943,568→ 2,943,568 total - Conversion
Series B-2 Preferred Stock
2020-07-28−9,593,086→ 0 total→ Common Stock (2,943,568 underlying) - Purchase
Common Stock
2020-07-28$19.00/sh+1,401,448$26,627,512→ 4,345,016 total - Conversion
Common Stock
2020-07-28+48,691→ 48,691 total - Purchase
Common Stock
2020-07-28$19.00/sh+23,552$447,488→ 72,243 total - Conversion
Series B-2 Preferred Stock
2020-07-28−158,687→ 0 total→ Common Stock (48,691 underlying)
Boxer Capital, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-07-28+2,943,568→ 2,943,568 total - Purchase
Common Stock
2020-07-28$19.00/sh+1,401,448$26,627,512→ 4,345,016 total - Purchase
Common Stock
2020-07-28$19.00/sh+23,552$447,488→ 72,243 total - Conversion
Series B-2 Preferred Stock
2020-07-28−158,687→ 0 total→ Common Stock (48,691 underlying) - Conversion
Series B-2 Preferred Stock
2020-07-28−9,593,086→ 0 total→ Common Stock (2,943,568 underlying) - Conversion
Common Stock
2020-07-28+48,691→ 48,691 total
Footnotes (6)
- [F1]Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date.
- [F2]The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC ("Boxer Capital") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC ("MVA Investors") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering. These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020.
- [F3]These securities are owned directly by Boxer Capital, which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the "Boxer Group"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein.
- [F4]These securities are owned directly by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
- [F5]On July 28, 2020, Boxer Capital purchased 1,401,448 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
- [F6]On July 28, 2020, MVA Investors purchased 23,552 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001468223
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 9:38 PM ET
- Size
- 21.1 KB